Compare Novacyt SAS with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
31.86%
0%
31.86%
6 Months
23.54%
0%
23.54%
1 Year
17.21%
0%
17.21%
2 Years
-26.5%
0%
-26.5%
3 Years
13.26%
0%
13.26%
4 Years
-70.53%
0%
-70.53%
5 Years
-88.52%
0%
-88.52%
Novacyt SAS for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
11.69%
EBIT Growth (5y)
-262.38%
EBIT to Interest (avg)
-0.11
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0.42
Tax Ratio
1.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
41.21%
ROE (avg)
16.84%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.59
EV to EBIT
-0.09
EV to EBITDA
-0.17
EV to Capital Employed
0.07
EV to Sales
0.07
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-78.72%
ROE (Latest)
-37.45%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Jun 2024
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.02%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
23.20
12.20
90.16%
Operating Profit (PBDIT) excl Other Income
-10.60
-13.70
22.63%
Interest
0.90
1.00
-10.00%
Exceptional Items
-23.40
-10.70
-118.69%
Consolidate Net Profit
-45.70
-27.70
-64.98%
Operating Profit Margin (Excl OI)
-833.60%
-1,470.00%
63.64%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 90.16% vs -50.61% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -64.98% vs -6.54% in Dec 2023
About Novacyt SAS 
Novacyt SAS
Pharmaceuticals & Biotechnology
Novacyt SA is a France-based company providing biotechnological solutions. The Company develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The Company provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The Company develops secure automated cytology named NovaPrep Processor System. Novacyt SA offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The Company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle. Novacyt SA is present in France and internationally through a network of distributors.
Company Coordinates 
Company Details
13 avenue Morane Saulnier , VELIZY VILLACOUBLAY None : 78140
Registrar Details






